TARO — Taro Pharmaceutical Industries Share News
0.000.00%
Last trade - 00:00HealthcareBalancedMid Cap
- $1.62bn
- $735.77m
- $629.18m
Taro Pharmaceutical Industries Ltd reports results for the quarter ended in March - Earnings Summary
Brief: Taro Posts Quarterly Loss Per Share Of $0.78
Taro Pharmaceutical Industries Ltd expected to post earnings of 92 cents a share - Earnings Preview
Taro Pharmaceutical Industries Ltd expected to post earnings of 92 cents a share - Earnings Preview
Japan vaccine supplies to be limited, delaying shots for elderly - minister (updated)
Japan vaccine supplies to be limited, delaying shots for elderly - minister
Brief: Taro Pharmaceutical Industries Quarterly Sales $140.1 Million
Brief: Taro Pharmaceutical Posts Quarterly Earnings Per Share $1.18
Brief: Taro Pharmaceutical Launches Specialty Generic Deferiprone Tablets, 500Mg In U.S.
Brief: Taro Provides Results For Quarter Ended June 30, 2020
Brief: Sun Pharma Unit To Acquire Aquinox Pharmaceuticals (Canada)
Taro Pharmaceuticals to pay more than $200 mln to settle U.S. price-fixing probe (updated)
Brief: Taro Achieves Global Resolution Of DOJ Antitrust Investigations
Taro Pharmaceuticals to pay more than $200 mln to settle U.S. price-fixing probe
Brief: Taro Reports Q4 Earnings Per Share Of $1.42
Brief: Taro Appoints New Chief Financial Officer
Brief: Taro Pharmaceuticals U.S.A. Issues Voluntary Nationwide Recall Of Phenytoin Oral Suspension USP, 125 Mg/5 Ml
Former executive of Taro Pharmaceutical indicted in U.S. for price-fixing
Taro Pharmaceutical: Falls after Q3 sales miss on generic drug pressures